Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...

ABBV's oncology sales might have dipped in Q2 as gains from newer drugs face pressure from Imbruvica's ongoing decline.

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.